{"id":324193,"date":"2022-11-08T09:20:22","date_gmt":"2022-11-08T14:20:22","guid":{"rendered":"https:\/\/www.sgtreport.com\/?p=324193"},"modified":"2022-11-07T21:33:24","modified_gmt":"2022-11-08T02:33:24","slug":"will-you-survive-the-tripledemic","status":"publish","type":"post","link":"https:\/\/www.sgtreport.com\/2022\/11\/will-you-survive-the-tripledemic\/","title":{"rendered":"Will You Survive the \u2018Tripledemic\u2019?"},"content":{"rendered":"
by Dr. Joseph Mercola, Mercola<\/a>:<\/em><\/p>\n <\/p>\n TRUTH LIVES on at\u00a0https:\/\/sgtreport.tv\/<\/a><\/p>\n According to mainstream media, hospitalizations for respiratory infections are on the rise and \u201cexperts\u201d warn of a potential \u201ctripledemic\u201d this winter, as people contract COVID,1<\/span><\/sup>\u00a0seasonal influenza and respiratory syncytial virus (RSV).2<\/span><\/sup><\/p>\n \u201cThe CDC [Centers for Disease Control and Prevention] reports a 1% increase in new admissions of patients with confirmed COVID-19 in the U.S.,\u201d<\/em>\u00a0Yahoo! News reported at the end of October 2022.3<\/span><\/sup><\/p><\/blockquote>\n Far from being a pandemic of the unvaccinated, however, most COVID patients are now, in fact, fully jabbed. As noted by Yahoo! News (before urging everyone to stay up to date on their boosters):<\/p>\n \u201cThe state with the most COVID hospitalizations is Maine even though it has one of the country\u2019s highest full vaccination rates, which means a person has received their primary series of vaccinations (whether that\u2019s one or two doses) and two weeks have passed since their last dose.\u201d<\/em><\/p><\/blockquote>\n RSV cases are also unseasonably high.4<\/span><\/sup>\u00a0According to Dr. Margaret R. Moon, co-director of Johns Hopkins Children\u2019s Center in Baltimore, the hospital \u201cis experiencing a surge of patients due to an increase in cases of RSV, as well as other reasons, and many surrounding hospitals are facing the same.\u201d5<\/span><\/sup><\/p>\n Fear sells, they say, and that\u2019s certainly the adage used by Big Pharma when it comes to vaccines. A perfect example of this was recently published by Vox.6<\/span><\/sup>\u00a0\u201cNew RSV Vaccines Are Coming. This Is Very, Very Good News,\u201d the headline states. Why good news? Because RSV is a \u201cbaddie responsible for much of the mayhem\u201d now seen in hospitals. Vox publishes classic fear porn:<\/p>\n \u201cRSV generally causes cold symptoms but can also lead to severe lung inflammation or infection in very young and very old people. And it\u2019s started off cold season with a bang:<\/em><\/p><\/blockquote>\n As of October 22, babies under a year old were being hospitalized at rates six times higher than they were at the same point in 2019, and the overall hospitalization rate was seven times higher for people of all ages.<\/em><\/p><\/blockquote>\n Every year, hundreds of children die of RSV, and tens of thousands more are hospitalized … RSV disease is one of the first pediatric illnesses that young pediatricians learn to fear, said [Amy] Edwards [a pediatric infectious disease specialist in Cleveland].<\/em><\/p><\/blockquote>\n Babies with the infection have terrible coughs and make wheezing noises as they struggle to move air through their swollen airways. \u2018Once you\u2019ve seen it, it\u2019s like you never forget it,\u2019 she said …<\/em><\/p><\/blockquote>\n In the US, the infection leads to about 58,000 hospitalizations and 100 to 300 deaths among young children each year, making it the country\u2019s top cause of hospitalization in infants.<\/em><\/p><\/blockquote>\n Although it\u2019s a particularly risky infection for babies born prematurely and for those with lung problems or heart abnormalities, about\u00a040 percent<\/a><\/strong>\u00a0of American infants who died of RSV over the past few decades were otherwise healthy.<\/em><\/p><\/blockquote>\n However bad RSV is in the United States, it\u2019s worse globally. Every year, it causes an estimated 120,000 infant deaths worldwide … There is currently no approved antiviral treatment for RSV in either adults or children, and the one preventive option that currently exists is far from perfect …<\/em><\/p><\/blockquote>\n Babies need something better \u2014 something affordable that can protect all infants, not just the highest-risk ones, from this seasonal scourge. Adults, too, need something to protect them from a virus that reliably causes an immense amount of disease \u2014 ideally, something that\u2019s as good as a flu shot, or better.\u201d<\/em><\/p><\/blockquote>\n \u201cSomething as good as a flu shot.\u201d Really? The 2017\/2018 seasonal influenza vaccine\u2019s adjusted overall effectiveness for the U.S. was just 36% against influenza A and influenza B virus infection,7<\/span>,8<\/span><\/sup>\u00a0and between 2005 and 2015, the flu vaccine\u2019s adjusted overall effectiveness was less than 50% more than half the time \u2014 with a low of only 10% in the 2004-05 season.9<\/span>,10<\/span><\/sup><\/p>\n Other than the COVID jab, it\u2019s difficult to find another example of where a commercial product can fail to work more than half the time and still be recommended and even mandated. Not to worry, though, because according to Vox, \u201cRSV vaccines are super effective.\u201d Where have we heard that before?<\/p>\n As predicted, \u201chealth experts\u201d are starting to call for voluntary indoor masking again,11<\/span><\/sup>\u00a0even though all the evidence garnered over the past three years confirms what we already knew in 2020, which is that\u00a0face masks do nothing to stop viral infections<\/a>.<\/p>\n And, as before, in the absence of actual scientific evidence the narrative focuses instead on virtue. Masking up is said to be a way to protect everyone,12<\/span><\/sup>\u00a0so just \u201cdo your part\u201d and wear it, even though, in reality, it protects no one.<\/p>\n The same goes for vaccination. Both the\u00a0flu vaccine<\/a>\u00a0and the\u00a0COVID shots<\/a>\u00a0are proven ineffective, yet the recommendation13<\/span><\/sup>\u00a0to get them continues. And this season, you\u2019re expected to get both!<\/p>\n The fact that RSV is now being highlighted as a severe risk is understandable in light of the fact that the first-ever RSV vaccines are now in the pipeline. According to CNN,14<\/span><\/sup>\u00a0four different RSV shots are \u201cnearing review by the U.S. Food and Drug Administration\u201d and more than a dozen others are in trials.<\/p>\n This includes a \u201clong-acting injection\u201d specifically for babies, to be given \u201cright after birth\u201d to protect them from RSV \u201cfor as long as six months.\u201d If that\u2019s not a perfect example of how media tries to change the perception of the basic meaning of a term, I don\u2019t know what is. Six months is hardly long-acting!<\/p>\n Historically, most vaccines have at least offered antibody-only \u201cprotection\u201d for years, not months. Please recognize all vaccines fail to use cellular immunity to protect you, which is far more important than humoral antibody protection. This extremely short duration of antibody-only protection appears to be a hallmark of mRNA technology however, and indeed, at least some of these new RSV shots are mRNA based.<\/p>\n<\/div>\nSTORY AT-A-GLANCE<\/h5>\n
\n
\n
Scare Tactics to Sell You on RSV Vaccine<\/h2>\n
\n
Expect Insane COVID Measures to Resume<\/h2>\n
First-Ever RSV Vaccines Expected in 2023<\/h2>\n